The Texatron™ platform is optimized for aneutronic fusion fuel cycles, with a primary focus on Deuterium–Helium-3 (D-He³).
Nonbinding Letter of Intent (LOI) sets framework for potential 2027 market entry in Ecuador and Colombia, followed by expansion into Peru, ...
In this dynamic and highly competitive biopharma landscape, the journey to commercialization success is fraught with complexities and challenges. Bringing a new product to market is an intricate ...
MORRISTOWN, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Lumanity today announced the launch of its new Value Inflection Point (VIP) Framework, a transformative approach designed to help biopharma ...
It’s been an interesting year on the pharma commercialization front. Amid all of the acquiring, investing and reorganizing, a few trends bubbled to the surface. Here are seven reflections, including ...
The framework agreement signifies a momentous stride in Indigenous communities' participation in clean technology solutions within the oil sands industry CVW CleanTech and Indigenous communities party ...
Nonbinding Letter of Intent (LOI) sets framework for potential 2027 market entry in Ecuador and Colombia, followed by expansion into Peru, Central America and the Caribbean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback